Denna sida på svenska

Maria Masucci

Professor

Documents

Publications

Emerging topics in human tumor virology
Masucci Mg, Rickinson Ab
Seminars in cancer biology 2014;26():1-3

Epstein-Barr virus encoded microRNAs target SUMO-regulated cellular functions
Callegari S, Gastaldello S, Faridani Or, Masucci Mg
The FEBS journal 2014;281(21):4935-50

Tumor viruses and replicative immortality--avoiding the telomere hurdle
Chen X, Kamranvar Sa, Masucci Mg
Seminars in cancer biology 2014;26():43-51

An N-terminal SIAH-interacting motif regulates the stability of the ubiquitin specific protease (USP)-19
Velasco K, Zhao B, Callegari S, Altun M, Liu H, Hassink G, et al
Biochemical and biophysical research communications 2013;433(4):390-5

Caspase-1 promotes Epstein-Barr virus replication by targeting the large tegument protein deneddylase to the nucleus of productively infected cells
Gastaldello S, Chen X, Callegari S, Masucci Mg
PLoS pathogens 2013;9(10):e1003664-

Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response
Guidi R, Guerra L, Levi L, Stenerlöw B, Fox Jg, Josenhans C, et al
Cellular microbiology 2013;15(1):98-113

Interaction of gamma-herpesvirus genome maintenance proteins with cellular chromatin
Mughal N, Coppotelli G, Callegari S, Gastaldello S, Masucci Mg
PloS one 2013;8(5):e62783-

Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus
Kamranvar Sa, Chen X, Masucci Mg
Oncogene 2013;32(49):5522-30

The Epstein-Barr virus nuclear antigen-1 reprograms transcription by mimicry of high mobility group A proteins
Coppotelli G, Mughal N, Callegari S, Sompallae R, Caja L, Luijsterburg Ms, et al
Nucleic acids research 2013;41(5):2950-62

The Gly-Ala repeat modulates the interaction of Epstein-Barr virus nuclear antigen-1 with cellular chromatin
Coppotelli G, Mughal N, Masucci Mg
Biochemical and biophysical research communications 2013;431(4):706-11

Herpes virus deneddylases interrupt the cullin-RING ligase neddylation cycle by inhibiting the binding of CAND1
Gastaldello S, Callegari S, Coppotelli G, Hildebrand S, Song M, Masucci Mg
Journal of molecular cell biology 2012;4(4):242-51

Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cells
Martorelli D, Coppotelli G, Muraro E, Dolcetti R, Masucci Mg
CANCER IMMUNOLOGY IMMUNOTHERAPY 2012;61(6):881-92

The ubiquitin specific protease-4 (USP4) interacts with the S9/Rpn6 subunit of the proteasome
Zhao B, Velasco K, Sompallae R, Pfirrmann T, Masucci Mg, Lindsten K
Biochemical and biophysical research communications 2012;427(3):490-6

Ubiquitin C-terminal hydrolase-L1 interacts with adhesion complexes and promotes cell migration, survival, and anchorage independent growth
Frisan T, Coppotelli G, Dryselius R, Masucci Mg
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012;26(12):5060-70

Bacterial genotoxin triggers FEN1-dependent RhoA activation, cytoskeleton remodeling and cell survival
Guerra L, Guidi R, Slot I, Callegari S, Sompallae R, Pickett Cl, et al
JOURNAL OF CELL SCIENCE 2011;124(16):2735-42

Helicobacter pylori affects the cellular deubiquitinase USP7 and ubiquitin-regulated components TRAF6 and the tumour suppressor p53
Coombs N, Sompallae R, Olbermann P, Gastaldello S, Goppel D, Masucci Mg, et al
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY 2011;301(3):213-24

High Avidity Binding to DNA Protects Ubiquitylated Substrates from Proteasomal Degradation
Coppotelli G, Mughal N, Marescotti D, Masucci Mg
JOURNAL OF BIOLOGICAL CHEMISTRY 2011;286(22):19565-75

The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress
Kamranvar Sa, Masucci Mg
LEUKEMIA 2011;25(6):1017-25

Thioredoxin 80-Activated-Monocytes (TAMs) Inhibit the Replication of Intracellular Pathogens
Cortes-bratti X, Basseres E, Herrera-rodriguez F, Botero-kleiven S, Coppotelli G, Andersen Jb, et al
PLOS ONE 2011;6(2):e16960-

A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases
Gastaldello S, Hildebrand S, Faridani O, Callegari S, Palmkvist M, Di Guglielmo C, et al
NATURE CELL BIOLOGY 2010;12(4):351-61

Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope
Marescotti D, Destro F, Baldisserotto A, Marastoni M, Coppotelli G, Masucci M, et al
IMMUNOLOGY 2010;129(3):386-95

The Translation Initiation Factor 3f (eIF3f) Exhibits a Deubiquitinase Activity Regulating Notch Activation
Moretti J, Chastagner P, Gastaldello S, Heuss Sf, Dirac Am, Bernards R, et al
PLOS BIOLOGY 2010;8(11):e1000545-

The ubiquitin C-terminal hydrolase UCH-L1 promotes bacterial invasion by altering the dynamics of the actin cytoskeleton
Basseres E, Coppotelli G, Pfirrmann T, Andersen Jb, Masucci M, Frisan T
CELLULAR MICROBIOLOGY 2010;12(11):1622-33

Transcription Profiling of Epstein-Barr Virus Nuclear Antigen (EBNA)-1 Expressing Cells Suggests Targeting of Chromatin Remodeling Complexes
Sompallae R, Callegari S, Kamranvar Sa, Masucci Mg
PLOS ONE 2010;5(8):e12052-

EBV and genomic instability-A new look at the role of the virus in the pathogenesis of Burkitt's lymphoma
Gruhne B, Kamranvar Sa, Masucci Mg, Sompallae R
SEMINARS IN CANCER BIOLOGY 2009;19(6):394-400

Influence of Helicobacter pylori on the expression and activity of deubiquitinating enzymes of human gastric epithelial cells
Lotzing N, Sompallae R, Olbermann P, Masucci Mg, Josenhans C
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY 2009;:32-32

Influence of H-pylori on the Expression and Activity of Deubiquitinating Enzymes of Human Gastric Epithelial Cells
Lotzing N, Sompallae R, Olbermann P, Masucci Mg, Josenhans C
HELICOBACTER 2009;14(4):328-329

The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species
Gruhne B, Sompallae R, Marescotti D, Kamranvar Sa, Gastaldello S, Masucci Mg
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2009;106(7):2313-8

The ER-resident ubiquitin-specific protease 19 participates in the UPR and rescues ERAD substrates
Hassink Gc, Zhao B, Sompallae R, Altun M, Gastaldello S, Zinin Nv, et al
EMBO REPORTS 2009;10(7):755-61

The ubiquitin C-terminal hydrolase UCH-L1 regulates B-cell proliferation and integrin activation
Rolen U, Freda E, Xie Jj, Pfirrmann T, Frisan T, Masucci Mg
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 2009;13(8B):1666-78

The ubiquitin specific protease 4 (USP4) is a new player in the Wnt signalling pathway
Zhao B, Schlesiger C, Masucci Mg, Lindsten K
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 2009;13(8B):1886-95

Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints
Gruhne B, Sompallae R, Masucci Mg
ONCOGENE 2009;28(45):3997-4008

A Bacterial Cytotoxin Identifies the RhoA Exchange Factor Net1 as a Key Effector in the Response to DNA Damage
Guerra L, Carr Hs, Richter-dahlfors A, Masucci Mg, Thelestam M, Frost Ja, et al
PLOS ONE 2008;3(5):e2254-

Epstein-Barr Virus Encodes Three Bona Fide Ubiquitin-Specific Proteases
Sompallae R, Gastaldello S, Hildebrand S, Zinin N, Hassink G, Lindsten K, et al
JOURNAL OF VIROLOGY 2008;82(21):10477-86

Inhibition of Serine-Peptidase Activity Enhances the Generation of a Survivin-Derived HLA-A2-Presented CTL Epitope in Colon-Carcinoma Cells
Preta G, Marescotti D, Fortini C, Carcoforo P, Castelli C, Masucci M, et al
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2008;68(6):579-88

The MAPK signaling cascade is a central hub in the regulation of cell cycle, apoptosis and cytoskeleton remodeling by tripeptidyl-peptidase II
Sompallae R, Stavropoulou V, Houde M, Masucci Mg
Gene regulation and systems biology 2008;2():253-65

Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma
Kamranvar Sa, Gruhne B, Szeles A, Masucci Mg
ONCOGENE 2007;26(35):5115-23

Expression of immune-related molecules in primary EBV positive chinese nasopharyngeal carcinoma: Associated with latent membrane protein 1 (LMP1) expression
Li J, Zhang Xs, Xie D, Deng Hx, Gao Yf, Chen Qy, et al
CANCER BIOLOGY & THERAPY 2007;6(12):1997-2004

Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy
Li J, Zeng Xh, Mo Hy, Rolen U, Gao Yf, Zhang Xs, et al
PLOS ONE 2007;2(11):e1122-

Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
Liu Jy, Wu Y, Zhang Xs, Yang Jl, Li Hl, Mao Yq, et al
CANCER IMMUNOLOGY IMMUNOTHERAPY 2007;56(10):1597-604

Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines
Rolen U, Kobzeva V, Gasparjan N, Ovaa H, Winberg G, Kisseljov F, et al
MOLECULAR CARCINOGENESIS 2006;45(4):260-9

GFP reporter mouse models of UPS proteolytic function
Lindsten K, Menendez-benito V, Masucci Mg, Dantuma Np
FASEB JOURNAL 2006;20(7):1027-author

Is the activity of partially agonistic MHC : Peptide ligands dependent on the quality of immunological help?
Uhlin M, Masucci M, Levitsky V
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2006;64(6):581-7

Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants
Majerova-uhlikova T, Dantuma Np, Lindsten K, Masucci Mg, Konvalinka J
JOURNAL OF CLINICAL VIROLOGY 2006;36(1):50-9

The ubiquitin-specific protease USP25 interacts with three sarcomeric proteins
Bosch-comas A, Lindsten K, Gonzalez-duarte R, Masucci Mg, Marfany G
CELLULAR AND MOLECULAR LIFE SCIENCES 2006;63(6):723-34

TPPII promotes genetic instability by allowing the escape from apoptosis of cells with activated mitotic checkpoints
Stavropoulou V, Vasquez V, Cereser B, Freda E, Masucci Mg
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2006;346(2):415-25

Endoplasmic reticulum stress compromises the ubiquitin-proteasome system
Menendez-benito V, Verhoef Lggc, Masucci Mg, Dantuma Np
HUMAN MOLECULAR GENETICS 2005;14(19):2787-99

Help signals provided by lymphokines modulate the activation and apoptotic programs induced by partially agonistic peptides in specific cytotoxic T lymphocytes
Uhlin M, Sandalova E, Masucci Mg, Levitsky V
EUROPEAN JOURNAL OF IMMUNOLOGY 2005;35(10):2929-39

Hepatitis C virus core protein induces an anergic state characterized by decreased interleukin-2 production and perturbation of mitogen-activated protein kinase responses
Sundstrom S, Ota S, Dimberg Ly, Masucci Mg, Bergqvist A
JOURNAL OF VIROLOGY 2005;79(4):2230-9

Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II
Stavropoulou V, Xie Jj, Henriksson M, Tomkinson B, Imreh S, Masucci Mg
CANCER RESEARCH 2005;65(4):1361-8

Regulation of lck degradation and refractory state in CD81 cytotoxic T lymphocytes
Uhlin M, Masucci Mg, Levitsky V
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2005;102(26):9264-9

The UBA2 domain functions as an intrinsic stabilization signal that protects Rad23 from proteasomal degradation
Heessen S, Masucci Mg, Dantuma Np
MOLECULAR CELL 2005;18(2):225-35

Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells
Ovaa H, Kessler Bm, Rolen U, Galardy Pj, Ploegh Hl, Masucci Mg
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2004;101(8):2253-8

Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication
Guerreiro-cacais Ao, Li Lq, Donati D, Bejarano Mt, Morgan A, Masucci Mg, et al
JOURNAL OF GENERAL VIROLOGY 2004;:2767-78

Differential regulation of MHC class-I-restricted and unrestricted cytotoxicity by the Us3 protein kinase of herpes simplex virus-1
Cartier A, Masucci Mg
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2004;60(6):592-9

Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients
Liu Dr, Tammik C, Zou Jz, Ernberg I, Masucci Mg, Ringden O, et al
CLINICAL TRANSPLANTATION 2004;18(5):518-24

Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system
Masucci Mg
ONCOGENE 2004;23(11):2107-15

Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering
Sandalova E, Wei Ch, Masucci Mg, Levitsky V
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2004;101(9):3011-6

Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
Issaeva N, Bozko P, Enge M, Protopopova M, Verhoef Lggc, Masucci M, et al
NATURE MEDICINE 2004;10(12):1321-8

A transgenic mouse model of the ubiquitin/proteasome system
Lindsten K, Menendez-benito V, Masucci Mg, Dantuma Np
NATURE BIOTECHNOLOGY 2003;21(8):897-902

Chemistry-based ubiquitin-specific protease profiling of virus infected and malignant human B cells.
Galardy Pj, Ovaa H, Kessler Bm, Rolen U, Ploegh Hl, Masucci Mg
BLOOD 2003;102(11):582A-582A

Epstein-Barr virus: Induction and control of cell transformation
Dolcetti R, Masucci Mg
JOURNAL OF CELLULAR PHYSIOLOGY 2003;196(2):207-18

Inhibition of ubiquitin/proteasome-dependent proteolysis in Saccharomyces cerevisiae by a Gly-Ala repeat
Heessen S, Dantuma Np, Tessarz P, Jellne M, Masucci Mg
FEBS LETTERS 2003;555(2):397-404

Pharmacological disintegration of lipid rafts decreases specific tetramer binding and disrupts the CD3 complex and CD8 heterodimer in human cytotoxic T lymphocytes
Uhlin M, Masucci Mg, Levitsky V
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2003;57(2):99-106

Reconstitution of the inhibitory effect of the Epstein-Barr virus Gly-Ala repeat on proteasomal degradation in yeast
Heessen S, Masucci Mg, Dantuma Np
FASEB JOURNAL 2003;17(4):A596-A596

Soluble factors released by virus specific activated cytotoxic T-lymphocytes induce apoptotic death of astroglioma cell lines
Sabri F, Chiodi F, Piret Jp, Wei Ch, Major E, Westermark B, et al
BRAIN PATHOLOGY 2003;13(2):165-75

The hepatitis C virus core protein modulates T cell responses by inducing spontaneous and altering T-cell receptor-triggered Ca2+ oscillations
Bergqvist A, Sundstrom S, Dimberg Ly, Gylfe E, Masucci Mg
JOURNAL OF BIOLOGICAL CHEMISTRY 2003;278(21):18877-83

The herpes simplex virus-1 Us3 protein kinase blocks CD8T cell lysis by preventing the cleavage of Bid by granzyme B
Cartier A, Broberg E, Komai T, Henriksson M, Masucci Mg
CELL DEATH AND DIFFERENTIATION 2003;10(12):1320-8

The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies
Dantuma Np, Masucci Mg
SEMINARS IN CANCER BIOLOGY 2003;13(1):69-76

The Us3 protein kinase of herpes simplex virus 1 blocks apoptosis and induces phosporylation of the Bcl-2 family member Bad
Cartier A, Komai T, Masucci Mg
EXPERIMENTAL CELL RESEARCH 2003;291(1):242-50

Aggregate formation inhibits proteasomal degradation of polyglutamine proteins
Verhoef Lggc, Lindsten K, Masucci Mg, Dantuma Np
HUMAN MOLECULAR GENETICS 2002;11(22):2689-700

Avoiding proteasomal processing: The case of EBNA1
Dantuma Np, Sharipo A, Masucci Mg
VIRAL PROTEINS COUNTERACTING HOST DEFENSES 2002;:23-36

Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4
Li Lq, Liu Dr, Hutt-fletcher L, Morgan A, Masucci Mg, Levitsky V
BLOOD 2002;99(10):3725-34

Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2-and HPV-E6-induced proteolysis
Heessen S, Leonchiks A, Issaeva N, Sharipo A, Selivanova G, Masucci Mg, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2002;99(3):1532-7

Immunotherapy of herpesvirus reactivation
Levitsky V, Li Lq, Wei C, Hutt-fletcher Lm, Morgan Aj, Masucci Mg
EUROPEAN JOURNAL OF CANCER 2002;:S9-S9

Inhibition of ubiquitin-dependent proteolysis by a synthetic glycine-alanine repeat peptide that mimics an inhibitory viral sequence
Leonchiks A, Stavropoulou V, Sharipo A, Masucci Mg
FEBS LETTERS 2002;522(1-3):93-8

Manipulation of immune responses by Epstein-Barr virus
Levitsky V, Masucci Mg
VIRUS RESEARCH 2002;88(1-2):71-86

Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation
Lindsten K, De Vrij Fms, Verhoef Lggc, Fischer Df, Van Leeuwen Fw, Hol Em, et al
JOURNAL OF CELL BIOLOGY 2002;157(3):417-27

Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation
Lindsten K, Verhoef Lggc, Masucci Mg, Dantuma N, De Vrij Fms, Fischer Df, et al
NEUROBIOLOGY OF AGING 2002;23(1):S516-S516

MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells
Staege Ms, Lee Sp, Frisan T, Mautner J, Scholz S, Pajic A, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2002;99(7):4550-5

Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors
Gavioli R, Vertuani S, Masucci Mg
INTERNATIONAL JOURNAL OF CANCER 2002;101(6):532-8

Stabilization signals: a novel regulatory mechanism in the ubiquitin/proteasome system
Dantuma Np, Masucci Mg
FEBS LETTERS 2002;529(1):22-6

Tetramer binding and secretion of interferon-gamma in response to antigenic stimulation are compatible with a range of affinities of MHC : TCR interaction and distinct programs of cytotoxic T-lymphocyte activation
Wei Ch, Uhlin M, Masucci Mg, Levitsky V
HUMAN IMMUNOLOGY 2002;63(10):821-33

The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells
Li Lq, Sharipo A, Chaves-olarte E, Masucci Mg, Levitsky V, Thelestam M, et al
CELLULAR MICROBIOLOGY 2002;4(2):87-99

Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity
Lindsten K, Uhlikova T, Konvalinka J, Masucci Mg, Dantuma Np
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2001;45(9):2616-22

cis-inhibition of proteasomal degradation by viral repeats: impact of length and amino acid composition
Sharipo A, Imreh M, Leonchiks A, Branden Ci, Masucci Mg
FEBS LETTERS 2001;499(1-2):137-42

c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells
Gavioli R, Frisan T, Vertuani S, Bornkamm Gw, Masucci Mg
NATURE CELL BIOLOGY 2001;3(3):283-8

Determination of antigen and fine peptide specificity of EBV-specific CTLs
Levitsky V, Frisan T, Masucci M
Methods in molecular biology (Clifton, N.J.) 2001;174():209-11

Different programs of activation-induced cell death are triggered in mature activated CTL by immunogenic and partially agonistic peptide ligands
Wei Ch, Yagita H, Masucci Mg, Levitsky V
JOURNAL OF IMMUNOLOGY 2001;166(2):989-95

Generation of lymphoblastoid cell lines (LCLs)
Frisan T, Levitsky V, Masucci M
Methods in molecular biology (Clifton, N.J.) 2001;174():125-7

Generation of polyclonal EBV-specific CTL cultures and clones
Levitsky V, Frisan T, Masucci M
Methods in molecular biology (Clifton, N.J.) 2001;174():203-8

Limiting dilution assay
Frisan T, Levitsky V, Masucci M
Methods in molecular biology (Clifton, N.J.) 2001;174():213-6

Regression assay
Frisan T, Levitsky V, Masucci M
Methods in molecular biology (Clifton, N.J.) 2001;174():199-201

Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway - Targeting via ubiquitination of the N-terminal residue
Aviel S, Winberg G, Massucci M, Ciechanover A
JOURNAL OF BIOLOGICAL CHEMISTRY 2000;275(31):23491-9

Effect of interleukin-7 on the in vitro development and maturation of monocyte derived human dendritic cells
Li Lq, Masucci Mg, Levitsky V
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2000;51(4):361-71

Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells
Gustafsson A, Levitsky V, Zou Jz, Frisan T, Dalianis T, Ljungman P, et al
BLOOD 2000;95(3):807-14

Evidence of selective processing of immunodominant epitopes in virally infected cells
Zhang Qj, Chen Ss, Saari Ca, Massuci Mg, Tufaro F, Jefferies Wa
JOURNAL OF IMMUNOLOGY 2000;164(9):4513-21

Inhibition of proteasomal degradation by the Gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal
Dantuma Np, Heessen S, Lindsten K, Jellne M, Masucci Mg
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2000;97(15):8381-5

Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells
Dantuma Np, Lindsten K, Glas R, Jellne M, Masucci Mg
NATURE BIOTECHNOLOGY 2000;18(5):538-43

Supermotif peptide binding and degeneracy of MHC: Peptide recognition in an EBV peptide-specific CTL response with highly restricted TCR usage
Levitsky V, Liu Dr, Southwood S, Levitskaya J, Sette A, Masucci Mg
HUMAN IMMUNOLOGY 2000;61(10):972-84

Ubiquitin/proteasome system - Reply
Masucci Mg, Dantuma Np
NATURE BIOTECHNOLOGY 2000;18(8):807-807

Variations in proteasome subunit composition and enzymatic activity in B-lymphoma lines and normal B cells
Frisan T, Levitsky V, Masucci Mg
INTERNATIONAL JOURNAL OF CANCER 2000;88(6):881-8

A partially agonistic peptide acts as a selective inducer of apoptosis in CD8(+) CTLs
Wei Ch, Beeson C, Masucci Mg, Levitsky V
JOURNAL OF IMMUNOLOGY 1999;163(5):2601-9

A single specific amino acid residue in peptide antigens is sufficient to activate memory CTL: Potential role of cross-reactive peptides in memory T cell maintenance
Reali E, Guerrini R, Marastoni M, Tomatis R, Masucci Mg, Traniello S, et al
JOURNAL OF IMMUNOLOGY 1999;162(1):106-13

CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines
Frisan T, Donati D, Cervenak L, Wilson J, Masucci Mg, Bejarano M
INTERNATIONAL JOURNAL OF CANCER 1999;83(6):772-9

Adoptive transfer of Epstein-Barr virus specific cytotoxic T-cells to patients at risk for posttransplant lymphoproliferative disease reduces the EBV DNA load in peripheral blood lymphocytes (PBL).
Gustafsson A, Levitsky V, Zou Jz, Winiarski J, Frisan T, Ljungman P, et al
BLOOD 1998;92(10):653A-653A

A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappa B alpha with the proteasome: A new mechanism for selective inhibition of proteolysis
Sharipo A, Imreh M, Leonchiks A, Imreh S, Masucci Mg
NATURE MEDICINE 1998;4(8):939-44

Avoiding immunity and apoptosis: Manipulation of the host environment by herpes simplex virus and Epstein-Barr virus
Hill Ab, Masucci Mg
SEMINARS IN VIROLOGY 1998;8(5):361-368

High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes
Gavioli R, Guerrini R, Masucci Mg, Tomatis R, Traniello S, Marastoni M
FEBS LETTERS 1998;421(2):95-9

Interleukin-10 abrogates the inhibition of Epstein-Barr virus-induced B-cell transformation by memory T-cell responses
Bejarano Mt, Masucci Mg
BLOOD 1998;92(11):4256-62

Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines
Frisan T, Levitsky V, Polack A, Masucci Mg
JOURNAL OF IMMUNOLOGY 1998;160(7):3281-9

Random coil conformation of a Gly/Ala-rich insert in I kappa B alpha excludes structural stabilization as the mechanism for protection against proteasomal degradation
Leonchiks A, Liepinsh E, Barishev M, Sharipo A, Masucci Mg, Otting G
FEBS LETTERS 1998;440(3):365-9

The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time
Levitsky V, De Campos-lima Po, Frisan T, Masucci Mg
JOURNAL OF IMMUNOLOGY 1998;161(2):594-601

Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus
Decamposlima Po, Levitsky V, Imreh Mp, Gavioli R, Masucci Mg
JOURNAL OF EXPERIMENTAL MEDICINE 1997;186(1):83-9

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1
Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci Mg
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 1997;94(23):12616-21

Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I : peptide complexes
Levitsky V, Zhang Qj, Levitskaya J, Kurilla Mg, Masucci Mg
JOURNAL OF IMMUNOLOGY 1997;159(11):5383-90

Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides
Reali E, Guerrini R, Giori B, Borghi M, Marastoni M, Tomatis R, et al
CLINICAL AND EXPERIMENTAL IMMUNOLOGY 1996;105(2):369-75

Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells
Frisan T, Zhang Qj, Levitskaya J, Coram M, Kurilla Mg, Masucci Mg
INTERNATIONAL JOURNAL OF CANCER 1996;68(2):251-8

HLA-A11-mediated protection from NK cell-mediated lysis - Role of HLA-A11-presented peptides
Gavioli R, Zhang Qj, Masucci Mg
HUMAN IMMUNOLOGY 1996;49(1):1-12

Local downregulation of the CD3 zeta chain in CD8(+) tumour associated T lymphocytes in primary Hodgkin's disease
Sjoberg J, Palucka K, Andersson M, Frisan T, Bjorkholm M, Grimfors G, et al
BRITISH JOURNAL OF HAEMATOLOGY 1996;:1095-1095

Solvent exposed side chains of peptides bound to HLA A*1101 have similar effects on the reactivity of alloantibodies and specific TCR
Zhang Qj, Lindquist Y, Levitsky V, Masucci Mg
INTERNATIONAL IMMUNOLOGY 1996;8(6):927-38

Strategies of immunoescape in Epstein-Barr virus persistence and pathogenesis
Decamposlima Po, Levitskaya J, Frisan T, Masucci Mg
SEMINARS IN VIROLOGY 1996;7(1):75-82

The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4
Levitsky V, Zhang Qj, Levitskaya J, Masucci Mg
JOURNAL OF EXPERIMENTAL MEDICINE 1996;183(3):915-26

EFFECT OF ANCHOR RESIDUE MODIFICATIONS ON THE STABILITY OF HLA-A11/PEPTIDE COMPLEXES
Gavioli R, Zhang Qj, Marastoni M, Guerrini R, Reali E, Tomatis R, et al
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 1995;206(1):8-14

IDENTIFICATION AND CHARACTERIZATION OF AN EPSTEIN-BARR VIRUS-SPECIFIC T-CELL RESPONSE IN THE PATHOLOGICAL TISSUE OF A PATIENT WITH HODGKINS-DISEASE
Dolcetti R, Frisan T, Sjoberg J, Decamposlima Po, Pisa P, De Re V, et al
CANCER RESEARCH 1995;55(16):3675-81

INHIBITION OF ANTIGEN-PROCESSING BY THE INTERNAL REPEAT REGION OF THE EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-1
Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwaldmullen Pm, Klein G, et al
NATURE 1995;375(6533):685-8

LOCAL SUPPRESSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXICITY IN BIOPSIES OF EBV-POSITIVE HODGKINS-DISEASE
Frisan T, Sjoberg J, Dolcetti R, Boiocchi M, De Re V, Carbone A, et al
BLOOD 1995;86(4):1493-501

MECHANISMS OF ALLELE-SELECTIVE DOWN-REGULATION OF HLA CLASS-I IN BURKITTS-LYMPHOMA
Imreh Mp, Zhang Qj, Decamposlima Po, Imreh S, Krausa P, Browning M, et al
INTERNATIONAL JOURNAL OF CANCER 1995;62(1):90-6

Show all publications